Dear Editor, Non-resorptive hydrocephalus results from disturbed reabsorption of cerebrospinal fluid (CSF) caused by damage to the absorptive tissue. The most common causes in adults are infections of the central nervous system (CNS) and haemorrhages as a consequence of intracerebral bleeding or craniocerebral injury. On accumulation of CSF, the ventricles expand and may cause an increase in intracranial pressure, which can damage the surrounding brain tissue. In non-resorptive hydrocephalus, decreased mental activity appears, including lethargy, apathy, impaired memory, and speech problems. Urinary and bowel incontinence can also occur.
In this report, we describe the unusual case of a young patient with Bcr-Abl positive acute lymphoblastic leukaemia (common B-ALL), who developed a non-resorptive hydrocephalus as a result of haemorrhagic ventriculitis during induction chemotherapy.
In August 2008, a 20-year-old woman was admitted to our hospital with recurrent infections. A comprehensive laboratory workup revealed a hyperleukocytosis of 50 × 10 9 /l as well as a severe anaemia of 5.81 g/dL (3.6 mmol/l) and thrombopenia of 14 × 10 9 /l. Differential blood count showed low numbers of granulocytes and lymphocytes accompanied by 61% blast cells. Bone marrow examination confirmed the diagnosis of an ALL (common B-ALL) with aberrant expression of CD13 and CD33. The ALL was classified as a very high-risk type, as molecular and cytogenetic analysis were positive for the Bcr-Abl fusion transcript and translocation t(9;22), respectively. No additional cytogenetic aberrations were found.
The patient was treated within the German Multicenter Adult ALL (GMALL 2003) therapy study and received induction treatment in accordance with the study protocol including prophylactic radiation of the brain and intrathecal chemotherapy parallel to the systemic chemotherapy. In addition, the patient received Imatinib, which inhibits BcrAbl tyrosine kinase activity, at 400 mg per day, starting on day 6 of the first induction chemotherapy.
There were no therapy-related complications seen through the first induction therapy. In October 2008, during the second induction therapy on day 8 of radiation therapy, the patient abruptly became somnolent and, afterwards, had a series of generalised epileptic seizures. Until then, the patient had received 1,670 mg cyclophosphamide on day 1, 125 mg cytarabine on days 3-6 and 10-11, 100 mg 6-mercaptopurine on days 1-11 of second induction therapy, 16 Gy of radiation therapy, and intrathecal application of 15 mg methotrexate (on days 3 and 11). Thereafter, intrathecal chemotherapy and cranial radiation were definitely stopped. In comparison to a previous 4-week-old normal computed tomography image (Fig. 1) , magnetic resonance imaging of the brain and brainstem now revealed an increasing lateral ventricular volume, due to a circulatory disturbance of the CSF (Fig. 2) . The third ventricle was slightly affected by volume increase. Consecutively, external CSF spaces were narrowed.
In addition, exiguous fluid levels were observed in the posterior horns of the lateral ventricles, which corresponded to blood accumulation. Increased CSF flow in the third and fourth ventricles as a consequence of dysfunctional CSF reabsorption was manifest. Dilated cortical vessels suggested a toxic impairment of the brain. Manifestations of lymphoma, sinus thrombosis, or major bleeding were excluded. Emergency intervention included insertion of an external ventricular drain. Several efforts to remove the drain resulted in somnolence and epileptic seizures, so that a permanent ventriculoperitoneal shunt was inserted by trepanation. Analyses of the CSF remained without detection of malignancy or infections.
Further observation and neuropsychological examination of the patient revealed a severe limitation of the short-term and long-term memory as well as distinctive difficulties in memory consolidation and learning. Compared to the previous status, fiddling and infantile behaviour was conspicuous.
Nevertheless, due to her good general condition and complete haematological remission, the second induction therapy and also the first consolidation therapy could be completed without giving intrathecal prophylactic chemotherapy again. In addition, the medication with Imatinib was ceased because of potential adverse effects on the CNS.
After first consolidation, the patient is still in complete haematologic remission and on the basis of a very high-risk disease, early allogenic stem cell transplantation is planned as second consolidation soon. Improvement of memory function could be achieved by intensive practicing.
CNS prophylaxis with intrathecal therapy and CNS radiation has significantly improved the outcome of patients with ALL [1] . Nevertheless, several authors have reported neurotoxicity and adverse effects on the CNS after the administration of intrathecal chemotherapy and/or cranial irradiation. Complications range from encephalopathy, seizures, and papilloedema to cauda equina syndrome, radiculopathy, and myelopathy [2, 3] .
In our case, findings indicated haemorrhagic ventriculitis as a cause of non-resorptive hydrocephalus internus. We propose a multifactorial genesis, with intrathecal chemotherapy, radiation, and Imatinib treatment contributing to high cumulative CNS toxicity and non-infectious inflammation of the lateral ventricles. (Fig. 1) . MRI shows a widened ventricle system with wide temporal horn and sedimentation of blood in the posterior horn (long arrow) and low signal in the cerebral aqueduct (short arrow). The outer cerebrospinal fluid spaces are narrowed Convulsion and increased intracranial pressure represent rare neurological adverse effects of Imatinib. Hydrocephalus has not been previously associated with Imatinib treatment.
Literature research revealed few reports of leucoencephalopathy associated with hydrocephalus after intrathecal chemotherapy or radiation. Most reports concerning chemotherapy-induced hydrocephalus correspond to longterm complications in children with ALL. Patients with solid tumours and cerebral metastases dominate in reports on adults. Contrary to our case after intrathecal chemotherapy, and also brain irradiation, hydrocephalus is usually a longterm complication, occurring several months after completion of therapy [4] [5] [6] . Fibrosis of arachnoid granulations inhibiting CSF reabsorption is proposed as a mechanism of radiation-induced hydrocephalus [6] .
In view of the limited prognosis and long-term sequelae, subsequent trials should emphasise the pathogenesis and aetiology of non-resorptive hydrocephalus after CNS prophylaxis in ALL patients.
